Tetramethylpyrazine induces the release of BDNF from BM‐MSCs through activation of the PI3K/AKT/CREB pathway

Abstract

Compelling evidences suggest that transplantation of bone marrow‐derived mesenchymal stem cells (BM‐MSCs) can be therapeutically effective for central nervous system (CNS) injuries and neurodegenerative diseases. The therapeutic effect of BM‐MSCs mainly attributes to their differentiation into neuron‐like cells which replace injured and degenerative neurons. Importantly, the neurotrophic factors released from BM‐MSCs can also rescue injured and degenerative neurons, which plays a biologically pivotal role in enhancing neuroregeneration and neurological functional recovery. Tetramethylpyrazine (TMP), the main bioactive ingredient extracted from the traditional Chinese medicinal herb Chuanxiong, has been reported to promote the neuronal differentiation of BM‐MSCs. This study aimed to investigate whether TMP regulates the release of neurotrophic factors from BM‐MSCs. We examined the effect of TMP on brain‐derived neurotrophic factor (BDNF) released from BM‐MSCs and elucidated the underlying molecular mechanism. Our results demonstrated that TMP at concentrations of lower than 200 μM increased the release of BDNF in a dose‐dependent manner. Furthermore, the effect of TMP on increasing the release of BDNF from BM‐MSCs was blocked by inhibiting the phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K)/protein kinase B (AKT)/cAMP‐response element binding protein (CREB) pathway. Therefore, we concluded that TMP could induce the release of BDNF from BM‐MSCs through activation of the PI3K/AKT/CREB pathway, leading to the formation of neuroprotective and proneurogenic microenvironment. These findings suggest that TMP possesses novel therapeutic potential to promote neuroprotection and neurogenesis through improving the neurotrophic ability of BM‐MSCs, which provides a promising nutritional prevention and treatment strategy for CNS injuries and neurodegenerative diseases via the transplantation of TMP‐treated BM‐MSCs.

What can traditional Chinese medicine do for adult neurogenesis?

“…Tetramethylpyrazine induces the release of BDNF from bone marrow mesenchymal stem cells by activating the PI3K/Akt/CREB pathway for neural differentiation. This effect could be reversed by the PI3K inhibitor LY294002 ( Chen et al, 2021 ).…”